Blood Fat Normalizing / Metabolic Optimizing / Anti-Aging Formula*
We are extremely happy to announce that Cholest-X™ is being reformulated and replaced with a vastly superior cholesterol-reducing formula called Metabolic MD™. When taken as directed Metabolic MD™ is a good tasting liposomal formula designed to achieve double the cholesterol-lowering effects than Cholest-X™. Metabolic MD™ is designed to work quickly, and then cost-effectively to keep blood fat levels normal.*
Metabolic MD™ is a synergistic, comprehensive evidence-based formulation* designed to:
- Attain 4 to 6 times the blood levels of ingredients compared to standard oral formulas*
- Achieve optimal bio-absorption, unexcelled bio-availability and superior bio-utilization compared to standard oral formulas*
- Accomplish regenerative medical outcomes in complex metabolic “group” disturbances such as excessive body fat, elevated blood cholesterol, high triglycerides, elevated LDL levels, abnormal HbA1c levels, and insulin dysregulation.*
- Provide fast reductions in cholesterol, triglyceride and LDL levels*
- Quickly achieve and maintain ideal weight and body mass index (BMI) outcomes, even for the more stubborn overweight cases*
- Help resolve the key underlying factors causing plaque and blood clots*
- Effectively suppresses: (1) Advanced glycation end products (or AGEs, which is regarded by medical authorities as the primary driving force to the aging process), and (2) assaults and injuries to the critical inner lining to blood vessels*
To achieve all of the above, Metabolic MD™ incorporates all non-GMO ingredients in a proprietary synergistic ratio* including:
- Liposomal Berberine
- Liposomal Irvingia gabonensis (IGOB-131®)
- Liposomal Camellia sinensis
- Select Liposomal Bioactivated B-Complex vitamins → Benfotiamine, P-5-P and Pantethine
- Select amino acids in Liposomal format → Acetyl-l-tyrosine and 5-HTP
- Key minerals → Liposomal Vanadium and Iodine
Take 5ml (1 teaspoon) twice daily in juice or liquid, at breakfast and dinner.
Metabolic MD™ is expected to become available this August.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- COMING SOON
- COMING SOON
Click here for Cholest-X Product Information Sheet
- Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9. Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ.
- Red yeast rice may be a statin substitute. People who are statin-intolerant due to side effects of muscle pain may benefit from this ancient Asian dietary and medicinal staple. Duke Med Health News. 2009 Sep;15(9):1-2.
- Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999 Feb;69(2):231-6. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL.
- Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am J Cardiol. 2010 Mar 1;105(5):664-6. Venero CV, Venero JV, Wortham DC, Thompson PD.
- Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J Am Coll Nutr. 2006 Feb;25(1):41-8. Moruisi KG, Oosthuizen W, Opperman AM.
- Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003 Aug;78(8):965-78. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R; Stresa Workshop Participants.
- The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis J Am Coll Nutr. 2009 Oct;28(5):517-24. Scholle JM, Baker WL, Talati R, Coleman CI.
- AHA Dietary and Lifestyle Recommendations Revised From Medscape Medical News
- Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000 Sep 13;284(10):1263-70. Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA.
- Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med. 2002 Jul 22;162(14):1568-76. Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter Research Group.
- Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia. Tokai J Exp Clin Med. 1981 Jan; (1):49-57. Hiramatsu K, Nozaki H, Arimori S.
- Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia] Acta Biomed Ateneo Parmense. 1987;58(5-6):143-52.
- Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Clin Ther. 1986;8(5):537-45. Arsenio L, Bodria P, Magnati G, Strata A, Trovato R.
- Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children. Int J Clin Pharmacol Ther Toxicol. 1986 Nov;24(11):630-7. Bertolini S, Donati C, Elicio N, Daga A, Cuzzolaro S, Marcenaro A, Saturnino M, Balestreri R.
- Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr. 2007 Jun;97(6):1187-95. Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LR.
- Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol. 2002 Jan;79(1):81-7. Anila L, Vijayalakshmi NR.
- Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr. 1988 Nov;42(11):939-44. Jacob A, Pandey M, Kapoor S, Saroja R.
- Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996 Feb;50(2):61-8. Mathur R, Sharma A, Dixit VP, Varma M.
- Ostlund Jr, R. (2004). "Phytosterols and cholesterol metabolism." Current opinion in lipidology 15(1): 37.
- Mattson, F. (1982). Optimizing the effect of plant sterols on cholesterol absorption in man, Am Soc Nutrition. 35: 697-700.
- Helske S, Miettinen T, Gylling H, Mäyränpää M, Lommi J, Turto H, Werkkala K, Kupari M, Kovanen PT. (2008). "Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves.". J Lipid Res 49 (7): 1511-8.
- De Jong, Plat, J and Mensink, RP (2003) Metabolic effects of plant sterols and stanols (review). Journal of Nutritional Biochemistry, 14: 362-9.
- European Commission (2002) General view of the Scientific Committee on Food on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects of beta-carotene
- Katan, MB, Grundy, SM, Jones P et al (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings, 78: 965-78.